MRE11 and neoplasm: Inhibiting MRE11 K673 lactylation enhances the efficacy of chemotherapy, and a small molecule peptide specifically inhibiting MRE11 K673 lactylation significantly improves the tumor‐killing effect of platinum‐based or PARP inhibitor chemotherapy in vitro and PDX models.